Cause of death, by non-communicable diseases, male in Libya
Libya: Cause of death, by non-communicable diseases, male was 58.1% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, male in Libya, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths.
Analysis
Libya recorded 58.1% for cause of death, by non-communicable diseases, male in 2021. That is the lowest value across all 6 years on record.
The figure is down 9.6% on the previous year and down 15.4% over ten years.
Over the whole period, cause of death, by non-communicable diseases, male in Libya peaked at 70.3% in 2019 and was at its lowest, 58.1%, in 2021.
That places Libya 100th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, male in Libya, year by year
| Year | % of total male deaths | Change |
|---|---|---|
| 2000 | 63.7% | — |
| 2010 | 68.7% | +7.9% |
| 2015 | 61.3% | -10.7% |
| 2019 | 70.3% | +14.7% |
| 2020 | 64.3% | -8.6% |
| 2021 | 58.1% | -9.6% |
Libya compared with similar countries
- Libya's 58.1% is below the median for upper middle income countries, which is 59.4%, 98% of the median. (55 countries reporting)
- Libya's 58.1% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 58.1%, 1.0× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 63.7% | 63.7% | 63.7% | 1 |
| 2010s | 66.8% | 61.3% | 70.3% | 3 |
| 2020s | 61.2% | 58.1% | 64.3% | 2 |
Countries ranked near Libya
- 97 Albania 59.3% compare
- 98 Bangladesh 58.8% compare
- 99 Dominican Republic 58.8% compare
- 101 Montenegro 57.7% compare
- 102 Argentina 57.4% compare
- 103 Myanmar 57.3% compare
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,084 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0404 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, male in Libya?
- Cause of death, by non-communicable diseases, male in Libya was 58.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, male recorded in Libya?
- The highest recorded value was 70.3% in 2019.
- What is the lowest cause of death, by non-communicable diseases, male recorded in Libya?
- The lowest recorded value was 58.1% in 2021.
- How does Libya rank for cause of death, by non-communicable diseases, male?
- Libya ranks 100th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, male rising or falling in Libya?
- Over the last ten years it is down 15.4%. The long-run trend across the full record is flat.
- Where does this Libya data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.